ID Business Solutions Ltd (IDBS)

Robot scientists: is this the lab of the future?

Paul Denny-Gouldson — Tue, 24 Feb 2015 11:44:00 GMT

Paul Denny-Gouldson, VP Strategic Solutions at IDBS, explores what the future holds for drug discovery laboratories.

Neural ID enables IDBS ELN users to audit biosignal content directly from reports

Mon, 12 May 2014 17:24:43 GMT

Neural ID, the provider of the only collaborative biosignal analytics platform spanning the pharmaceutical lifecycle, teams up with IDBS for customer-focused collaboration. Launched during the recent Bio-IT World Conference & Expo in Boston, US...

Latest ELN Release Delivers Advanced Chemical Functionality

Tue, 07 Jan 2014 16:04:34 GMT

IDBS has added key data visualisation and data analysis capabilities to E-WorkBook 9.4. The new chemical drawing features enable users to capture a wider variety of molecular types and streamlines chemistry data input.

Data-Centric ELN Supports Collaboration and Multidiscipline Activity

Wed, 25 Sep 2013 11:35:00 GMT

IDBS’s E-Workbook suite recently saw major enhancements to its web client. Furthermore, the latest 9.3 release also includes integration with IDBS’s workflow and analytics engine and new asset tracking and management technology.

EDM Platform Release Enhances Web Experience and Workflow Support

Wed, 22 May 2013 15:16:00 GMT

IDBS has extended the capabilities of E-WorkBook, offering major enhancements to the web client and integrations with IDBS’ workflow and analytics engine. A new asset handling technology has also been released.

ELN Specialist Achieves Very High Rating in Six Categories of Research Report

Tue, 15 Jan 2013 16:20:00 GMT

IDBS is one of only five firms out of 34 to be rated as an ELN Enterprise Vendor in Gartner’s research report titled ‘Manufacturers Must Consider Scientific Domain Expertise During ELN Selection’, published 11 January 2013.

Seattle Genetics Uses ELN to Capture Experimental Data for Efficient Study and Process Management

Mon, 10 Dec 2012 14:16:00 GMT

IDBS has announced that Seattle Genetics, Inc. — a leader in antibody-drug conjugate development — chose its E-WorkBook, an ELN that supports a broad range of scientific disciplines within one single platform...